Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
154.50
-9.00 (-5.50%)
Jul 16, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 16.64 billion as of July 15, 2026. Its market cap has increased by 22.15% in one year.
Market Cap
16.64B
Enterprise Value
15.51B
Revenue
1.03B
Ranking
n/a
PE Ratio
32.52
Stock Price
154.50
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 16.64B, an increase of 226.51%. That is a compound annual growth rate of 16.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 16.64B | 15.82% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.30B |
| CHO Pharma | 22.26B |
| Sunmax Biotechnology | 20.75B |
| ACRO Biomedical | 18.30B |
| TaiMed Biologics | 17.84B |
| Lumosa Therapeutics | 16.15B |
| Medigen Vaccine Biologics | 15.71B |
| TCM Biotech International | 14.70B |